Biosafety Open Forum
Industry Workshop on the Present and Future
of NGS-Based Biosafety Testing, co-hosted by BMS
First Virtual Industry Workshop on NGS-Based Biosafety Testing
In collaboration with Bristol-Myers Squibb, Genedata Selector organized and co-hosted an industry workshop on December 10th, 2020.
This interactive event brought together key experts from 9 companies to facilitate knowledge sharing and industry discussions related to key challenges and opportunities in the field of biosafety testing. Featured themes included NGS-based adventitious virus detection, its impact in accelerating clinical timelines, and the benefits and challenges related to implementation in biopharma companies.
This event was an opportunity for the biopharma industry to raise questions to experts in the field while sharing and exchanging ideas regarding best practices using NGS-based biosafety as well as the need to identify adventitious agents during biopharma R&D.
Rapid Methods for Adventitious Virus Detection - Acceleration of Clinical Timelines - Speed to Patient
Jürgen Müllberg, Principal Scientist Viral Safety SME, BMS
Integration of NGS Biosafety Methods in Biopharma Companies - Benefits & Current Limitations
Fabio La Neve, Head of Analytical Development, Ibex at Lonza
Horses for Courses: Thoroughbred Bioinformatics Pipelines for Virologists
Sebastien Ribrioux, Head of Scientific Consulting Genedata
Agenda of Industry Workshop on December 10th, 2020
|9:00||15:00||Welcome and Introduction to the Participants||Anurag Khetan, Senior Director Biologics Development, Bristol-Myers Squibb & Thomas Hartsch, Head of Genedata Selector|
|9:15||15:15||Rapid Methods for Adventitious Virus Detection: Acceleration of Clinical Timelines - Speed to Patient||Jürgen Müllberg, Principal Scientist / Viral Safety SME, Bristol-Myers Squibb|
Integration of NGS Biosafety Methods in Biopharma Companies: Benefits and Current Limitations
|Fabio La Neve, Head of Analytical Development, Ibex at Lonza|
|10:05||16:05||Horses for Courses: Thoroughbred Bioinformatics Pipelines for Virologists||Sebastien Ribrioux, Head of Scientific Consulting, Genedata|
|10:40||16:40||OPEN DISCUSSION||All Participants, moderated by Genedata|
|11:50||17:50||Demonstration of Viral Safety Data Analysis Workflow||Namrata Sarkar, Scientific Account Manager, Genedata|
12:00 - 12:10
18:00 - 18:10
|Final Remarks||Thomas Hartsch, Head of Genedata Selector|